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Pneumococcal Pneumolysin 
Induces DNA Damage and Cell Cycle 
Arrest
Prashant Rai1,2, Fang He3, Jimmy Kwang2,3, Bevin P. Engelward1,4,* & Vincent T.K. Chow1,2,*
Streptococcus pneumoniae produces pneumolysin toxin as a key virulence factor against host cells. 
Pneumolysin is a cholesterol-dependent cytolysin (CDC) toxin that forms lytic pores in host membranes 
and mediates pneumococcal disease pathogenesis by modulating inflammatory responses. Here, we 
show that pneumolysin, which is released during bacterial lysis, induces DNA double strand breaks 
(DSBs), as indicated by ataxia telangiectasia mutated (ATM)-mediated H2AX phosphorylation (γH2AX). 
Pneumolysin-induced γH2AX foci recruit mediator of DNA damage checkpoint 1 (MDC1) and p53 
binding protein 1 (53BP1), to sites of DSBs. Importantly, results show that toxin-induced DNA damage 
precedes cell cycle arrest and causes apoptosis when DNA-dependent protein kinase (DNA-PK)-
mediated non-homologous end joining is inhibited. Further, we observe that cells that were undergoing 
DNA replication harbored DSBs in greater frequency during pneumolysin treatment. This observation 
raises the possibility that DSBs might be arising as a result of replication fork breakdown. Additionally, 
neutralizing the oligomerization domain of pneumolysin with monoclonal antibody suppresses DNA 
damage and also cell cycle arrest, indicating that pneumolysin oligomerization is important for causing 
DNA damage. Taken together, this study reveals a previously unidentified ability of pneumolysin 
to induce cytotoxicity via DNA damage, with implications in the pathophysiology of S. pneumoniae 
infection.
Severe pneumonia caused by Streptococcus pneumoniae results in significant mortality due to various compli-
cations, including pulmonary edema secondary to alveolar-capillary barrier destruction1 and cardiovascular 
failure1–3. Intriguingly, complications can persist even after antibiotic intervention that eliminates the pneumo-
cocci1,3. These observations call attention to the potential for molecular components of pneumococci to induce 
cytotoxicity, rather than the live organism. As such, it is important to understand the host responses during 
bactericidal antibiotic treatment, since responses toward pneumococcal proteins that remain in circulation may 
influence disease severity and progression. Pneumolysin, a toxin produced by S. pneumoniae, is known to be 
released during enzyme-mediated autolysis4, competence-induced lysis5 and antibiotic-mediated lysis of pneu-
mococci6. Importantly, pneumolysin has been shown to be crucial for pneumococcal virulence and invasion 
in vivo7,8. While pneumolysin-induced cytotoxicity is well-documented9–11, the molecular processes underlying 
its toxicity are not yet fully understood.
Pneumolysin belongs to a cholesterol-dependent cytolysin (CDC) family of toxins, which are produced by 
Gram-positive bacteria1. CDCs primarily mediate host cell death by binding to membrane cholesterol and then 
oligomerizing to form macromolecular pores that perforate the host membrane to mediate cell lysis12,13. In animal 
models of infection, the lytic activity of pneumolysin is associated with disruption of alveolar-capillary barrier, 
which exacerbates disease severity14,15. Indeed, purified pneumolysin can directly cause vascular leakage and 
edema16. Pneumolysin present in the systemic circulation has also been shown to cause myocardial injury during 
pneumococcal infection17. Moreover, pneumolysin triggers activation of pro-inflammatory immune cells, lead-
ing to release of reactive oxygen and nitrogen species that damage host tissues18,19. Taken together, these studies 
implicate pneumolysin as a key protein in the mediation of disease severity.
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In addition to the ability to induce membrane-mediated toxicity and to activate immune responses, there is 
also accumulating evidence that CDC toxins play additional roles in modulating cell signaling and function13. 
Specifically, recent studies have called attention to infection-induced DNA damage as a possible pathogenicity 
factor20,21. Of particular interest is the impact of pneumolysin on formation of DNA double strand breaks (DSBs). 
DSBs are considered to be one of the most toxic forms of DNA damage as they can cause chromosomal rear-
rangements and even cell death if they are not properly repaired22. The process of DSBs repair is initiated by ATM 
kinase-mediated phosphorylation of histone variant H2AX to form γ H2AX23. Foci of γ H2AX at DSBs serve to 
recruit repair proteins such as 53BP124 that facilitates repair of DSBs via non-homologous end joining (NHEJ) 
pathway25. During G1, NHEJ pathway26 is initiated when the heterodimer complex of Ku70-Ku80 binds to broken 
DNA ends. The Ku complex recruits catalytic DNA-PKc to form complete holoenzyme DNA-PK, which facili-
tates the processing of damaged termini by Artemis and ligase IV27. To prevent the deleterious effects of DSBs, in 
addition to facilitating repair, ATM can activate cell cycle arrest mainly via checkpoint kinase 2 (Chk2)28, allowing 
time for the repair of DSBs. Despite the presence of repair pathways and cell cycle arrest, under severe conditions, 
DNA damage can persist and drive the cellular response towards apoptosis29, thus eliminating cells that would 
otherwise suffer from genomic instability. Hence, the extent of DNA damage and the resultant cellular responses 
determine cell fate under stress.
Given that the pneumococcal toxin pneumolysin is associated with apoptosis9 and that DNA damage can 
trigger apoptosis22, here we investigated the possibility that pneumolysin causes DNA damage and its down-
stream sequelae. We found that even in the absence of live bacterial cells, pneumolysin is able to induce DSBs 
in alveolar epithelial cells. In addition, we also show that pneumolysin-induced DNA damage is associated with 
cell cycle arrest and that pneumolysin binding and oligomerization in the membrane plays significant role in its 
genotoxicity. Finally, results from these studies show that pneumolysin-induced DSBs give rise to repair foci and 
that inhibition of DSB repair exacerbates pneumolysin-induced toxicity, pointing to DNA repair as a potentially 
important susceptibility factor. Taken together, the results of these studies reveal that pneumolysin is genotoxic, 
thus providing a molecular mechanism that potentially contributes to pneumolysin’s pathogenicity.
Results
Pneumolysin induces DNA damage and cell lysis. Pneumolysin toxin is mostly found in the cyto-
plasm of S. pneumoniae and it cannot be actively secreted as it lacks a secretory signal30. Therefore, the biological 
relevance of pneumolysin is specific to lysed bacterial cells. To explore the ability of pneumolysin to cause DNA 
damage, we therefore first investigated whether pneumococcal lysate can induce host DNA damage. We exposed 
alveolar epithelial cells to lysate of pneumococcal protoplasts of three different serotypes, namely − 19 F, 3 and 4 
(Fig. 1A). The frequency of γ H2AX foci, which form at sites of DSBs, was measured after exposure. We found that 
lysates from all three serotypes induced a significant increase in the frequency of γ H2AX positive cells (≥ 5 foci 
per nucleus). These data raise the possibility that pneumolysin, which is released after lytic death of bacteria, can 
induce DNA repair foci.
To further probe the potential for pneumolysin to induce DNA damage, we created recombinant pneumo-
lysin. Alveolar epithelial cells were exposed to recombinant pneumolysin (Fig. 1B) and analyzed to determine 
the levels of γ H2AX foci and 53BP1 foci, a downstream DNA repair protein that frequently colocalizes with 
γ H2AX24 and helps to direct the DSB repair toward non-homologous end joining25. We observed that pneumo-
lysin induces discrete foci of γ H2AX and 53BP1 in epithelial cells, in a concentration dependent manner. Visual 
inspection suggests that at 1 μg/ml, pneumolysin induced a greater number of DNA damaged cells than at 0.1 μg/
ml (Fig. 1B). In addition, we observed that most γ H2AX foci induced by pneumolysin colocalized with 53BP1, 
which is consistent with the formation of DSBs. We further investigated kinetics of the occurrence of DSBs in 
alveolar epithelial cells for up to 48 h of pneumolysin treatment (Fig. 1C). We found that recombinant pneu-
molysin was able to induce DSBs in significant percentage of cells as early as 4 h, with maximum DNA damage 
around 12 h. We also observed that at 12 h post-incubation, the higher concentration of pneumolysin (1 μg/ml) 
was able to induce DSBs in over 60% of host cells compared to ~40% induced by 0.1 μg/ml pneumolysin (Fig. 1C). 
Furthermore, the frequency of alveolar epithelial cells harboring DSBs decreased after ~12 h. Given that DSBs are 
able to activate repair processes as an integral part of DNA damage responses, the decline in the percentage of 
cells harboring DNA damage is consistent with DSBs repair. To further reveal the proteins that are present in the 
repair foci, we analyzed the pneumolysin-induced γ H2AX foci for the presence of another DNA repair protein, 
namely MDC1. MDC1 binds to γ H2AX31, creating a platform for recruitment of phospho-ATM, which leads to 
phosphorylation of various repair proteins, including 53BP131. We observed that pneumolysin-induced γ H2AX 
foci indeed colocalize with MDC1 protein, indicating activation of DNA damage responses (Fig. 1D). Consistent 
with accumulation of damage response proteins at pneumolysin-induced repair foci, we observed that 53BP1, 
which colocalized with γ H2AX foci, is also phosphorylated (Supplementary Fig. 1). These data provide strong 
evidence that pneumolysin-induced γ H2AX foci are indeed associated with DSBs.
There are many reports showing that pneumolysin disrupts the host cell membrane9,11. Hence, we also ana-
lyzed release of cytoplasmic lactate dehydrogenase (LDH) as an indicator of pneumolysin-induced membrane 
pores (Fig. 1C). We found that pneumolysin causes significant LDH release from alveolar epithelial cells at 1 μg/
ml concentration but did not cause any detectable cell lysis at 0.1 μg/ml. Given that pneumolysin was genotoxic 
at 0.1 μg/ml, this result suggests that pneumolysin is able to induce DSBs without significantly disrupting the host 
cell membrane. Overall, these data suggest that pneumolysin released during pneumococcal lysis is able to induce 
discrete γ H2AX foci as well as potential repair responses, even in the absence of significant cell lysis.
Pneumolysin induces ATM and activates DNA-PK mediated repair. To further reveal DNA dam-
age responses during pneumolysin-induced DSBs, we studied phosphatidylinositol 3-kinase related kinases 
(PI3KK), which play important roles in response to DNA damage27. Specifically, DSBs activate response pathways 
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that are regulated by PI3KK proteins, including ATM kinase, which phosphorylates H2AX23. To learn whether 
pneumolysin-induced DSBs activate the canonical ATM kinase pathway, we treated alveolar epithelial cells with 
an ATM kinase inhibitor (KU55933) at the same time as being exposed to pneumolysin (Fig. 2A). We found that 
inhibition of ATM kinase significantly reduces formation of γ H2AX (Fig. 2B). We also observed that there were 
neither significant levels of apoptosis in the adherent epithelial cells (indicated by TUNEL staining) (Fig. 2C) nor 
detached cells in culture supernatant (Fig. 2D). However, there was a significant reduction in total cellular ATP 
content when epithelial cells were exposed to pneumolysin in presence of 20 μM KU55933 (Fig. 2E), indicating 
a decline in metabolic activity when the ATM pathway is inhibited. In addition, we also observed that the most 
genotoxic concentration of pneumolysin (1 μg/ml) led to a greater reduction in cellular ATP (Fig. 2E). These 
observations are consistent with pneumolysin-induced DNA damage activating the ATM response pathway, inhi-
bition of which results in decreased γ H2AX foci and metabolic activity.
DNA-PKcs is another member of the PI3KK family that plays an important role in the DNA damage 
response32. Specifically, DNA-PKcs interacts with Ku70 and Ku80 to form the DNA-PK holoenzyme, which 
is essential for repair of DSBs via the NHEJ pathway27. We challenged cells that were exposed to pneumoly-
sin with exposure to the DNA-PKcs inhibitor NU7441 (Fig. 2A). We observed a significant reduction in 
pneumolysin-induced γ H2AX formation, which is consistent with previous studies showing that a significant 
proportion of γ H2AX results from phosphorylation by DNA-PKcs32 (Fig. 2B). Additionally, exposure to NU7441 
resulted in increased apoptosis of alveolar epithelial cells (TUNEL positive) during exposure to high pneumo-
lysin concentration (Fig. 2C). Furthermore, inhibition of DNA-PK during pneumolysin exposure resulted in 
a significant decrease in ATP levels in alveolar cells (Fig. 2E) and a parallel increase in number of detached 
cells in the culture supernatant (Fig. 2D). The observation of apoptotic cells and presence of detached cells in 
culture during NU7441 treatment suggests that the decrease in ATP levels is due to loss of viable cells. Overall, 
DNA-PK inhibition during pneumolysin-induced DNA damage exerted greater detrimental effect on cell sur-
vival than ATM inhibition. This may be attributed to the indispensable role of DNA-PK in NHEJ repair path-
way, such that its inhibition impairs DNA repair and leads to cell death. Taken together, these findings indicate 
that pneumolysin-induced DSBs activate the ATM pathway. Finally, suppression of DNA DSB repair via inhibi-
tion of DNA-PKcs results in increased pneumolysin-induced cell death, pointing to the potential importance of 
pneumolysin-induced DSBs in cell fate.
Figure 1. Pneumolysin induces cell DNA damage and cell lysis. (A) Lysate of pneumococcal protoplast 
induces DNA damage in alveolar epithelial cells. S. pneumoniae serotypes 19F, 3 and 4, grown in bacteria media, 
are re-suspended in cell wall digestion buffer to isolate the protoplasts, which are then physically lysed by Bead 
beater in F12-K culture media. The pneumococcal lysates are then incubated with alveolar epithelial cells for 
7 h and analyzed for γ H2AX. Representative images of three independent experiments showing γ H2AX (red) 
and nuclei (blue). (B,C) Pneumolysin induces double strand breaks (DSBs) in alveolar epithelial cells. (B) 
Recombinant pneumolysin was incubated with alveolar epithelial cells at 0.1 μg/ml and 1 μg/ml concentration 
for 12 h and analyzed for γ H2AX and 53BP1. Representative images showing DSBs in alveolar epithelial cells 
with nuclei (blue), γ H2AX (red), 53BP1 (green) and colocalized foci (yellow). (C) Alveolar epithelial cells 
exposed to pneumolysin were analyzed for γ H2AX and 53BP1 at 4, 8, 12, 24 and 48 h of incubation. γ H2AX 
and 53BP1 positive cells (≥ 5 foci per nucleus) were quantified and expressed as percentage positive cells. 
Cytotoxicity was quantified by using LDH assay and expressed as percent of total LDH release during lysis 
by 1% Triton X-100. (D) Representative images showing DSBs in alveolar epithelial cells with nuclei (blue), 
γ H2AX (red), MDC1 (green) and colocalized foci (yellow). ‘Media’ indicates negative control without any 
pneumolysin. Results show mean ± SEM for three independent experiments.
www.nature.com/scientificreports/
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Pneumolysin induces cell cycle arrest. In addition to the ability of pneumolysin-induced DNA 
damage to cause cell death during inhibition of DNA repair, we were also interested in the possibility that 
pneumolysin-induced DNA damage can affect cell cycle progression. DNA damage-induced p53 activation 
Figure 2. Pneumolysin-induced DNA damage response is mediated by ATM and activates DNA-PK-
mediated repair. (A) Alveolar epithelial cells were incubated with pneumolysin at 0.1 μg/ml and 1 μg/ml 
concentration for 6 h, in the presence of 10 μM and 20 μM of ATM inhibitor (KU55933) or DNA-PK inhibitor 
(NU7441) in DMSO. Representative images showing inhibition of γ H2AX formation by KU55933 and NU7441 
as well as apoptosis induction by NU7441, with nuclei (blue), γ H2AX (red) and TUNEL (green). Images are 
representative from four independent experiments. (B) γ H2AX positive (≥ 5 foci per nucleus) and (C) TUNEL 
positive cells were quantified and expressed as percentage positive cells. (D) During pneumolysin treatment 
with KU55933 or NU7441, the numbers of detached cells in the culture medium were determined using 
hemocytometer and expressed as percentage of cells initially seeded (1 × 105). (E) The overall ATP content in 
each well was determined and expressed as percentage of total ATP in the negative control (DMSO-treated, 
No PLY). Results show mean ± SEM for three independent experiments. *p < 0.05, unpaired Student’s t-test 
between DMSO and inhibitor treatment conditions.
www.nature.com/scientificreports/
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following exposure to relatively low levels of damage can lead to cell cycle arrest, allowing time for repair, whereas 
relatively high levels of damage can lead to p53 mediated apoptosis33. Given the pivotal role of p53 expression in 
cell fate34,35, first we examined the level of p53 protein during pneumolysin treatment. Figure 3A shows that there 
appears to be an increase in p53, however the result was not statistically significant (in terms of band intensity), 
Although we did not observe a significant increase in the levels of p53, it remained possible that downstream 
targets of p53 might still be activated. One of the important proteins that regulates cell cycle progression is p21, 
which inhibits cell cycle promoting cyclin-dependent kinases (CDK1 and CDK236,37) to sustain cell arrest signals 
during DNA damage38. We found significantly increased levels of p21 at 24 h of pneumolysin treatment, indicat-
ing potential induction of cell cycle arrest (Fig. 3A). Indeed, when the cell cycle status of pneumolysin-treated 
cells was determined by analyzing their DNA content, we observed that a significant percentage of cells were 
arrested at 4N DNA content of late S-phase and G2/M transition phase cells at 24 and 48 hours (Fig. 3B). Similar 
to the pneumolysin-induced DNA damage, the extent of pneumolysin-induced cell arrest was also dependent 
on its concentration, with higher genotoxic concentration inducing greater percentage of arrested cells. Overall, 
these data suggest that pneumolysin-induced DSBs are associated with cell cycle arrest.
Pneumolysin-induced DNA damage is associated with DNA replication. During DNA repli-
cation, replication forks can break down when they encounter a single strand break (SSB)39, which can cause 
the formation of a double strand end that can lead to H2AX phosphorylation. In addition, replication stress 
due to stalling or slowing of replication fork is also known to cause H2AX phosphorylation40. To learn whether 
pneumolysin-induced DNA damage is associated with DNA replication, pneumolysin exposed cells were pulsed 
with EdU for 30 minutes at intervals of 4, 12 and 48 h of exposure and fixed immediately to analyze for γ H2AX 
and EdU (Fig. 4). Here, the population of γ H2AX and EdU positive cells depicts actively replicating cells with 
DNA damage. At 12 h, we observed that ~26% of total γ H2AX-positive cells, induced by 0.1 μg/ml pneumolysin, 
were EdU-positive (Fig. 4). Similarly, ~22% of γ H2AX-positive cells were also EdU positive during 1 μg/ml pneu-
molysin treatment. These results indicate that during pneumolysin induced genotoxicity, a sub-population of 
DNA damaged cells are also undergoing DNA replication, raising the possibility that pneumolysin-induced DNA 
damage could be associated with replication stress or fork breakdown. At 48 h, we did not observe any significant 
number of cells that were positive for both replication and DNA damage (Fig. 4), possibly due to reduced replica-
tion as a result of cell arrest at 48 h (Fig. 3B). Taken together, these results suggest that pneumolysin-induced DNA 
damage is partly associated with DNA replication.
Neutralizing pneumolysin prevents DNA damage and cell arrest. Pneumolysin is known to make 
pores in cell membrane by oligomerization of 35–47 monomers that assemble into a pre-pore structure which 
undergoes conformational changes to form a complete 26 nm ring-shaped pore, characteristic of CDC family12. 
Given that oligomerization of pneumolysin is the initial process in eliciting cellular responses, we sought to 
understand the role of oligomerization in pneumolysin-induced DSBs. To learn about the impact of oligomeriza-
tion, we generated a monoclonal antibody (mAb) against the oligomerizing domain of recombinant pneumolysin 
and we showed that it neutralizes the hemolytic ability of toxin by preventing oligomerization and subsequent 
pore formation in erythrocytes (Fig. 5A). We then tested the ability of the mAb to neutralize cytotoxicity of pneu-
molysin in alveolar epithelial cells and found that the mAb was able to reduce pneumolysin-induced LDH release 
from alveolar epithelial cells (Fig. 5B). We next asked about the impact of oligomerization on DNA damage. 
Remarkably, alveolar epithelial cells exposed to pneumolysin in the presence of mAb showed a significant reduc-
tion in the frequency of cells with DSBs, as indicated by γ H2AX staining (Fig. 5C). In addition, pre-treatment 
of pneumolysin with cholesterol, which binds to pneumolysin and competitively inhibits its attachment to 
membrane cholesterol, also diminished DNA damage caused by pneumolysin (Supplementary Fig. 2). These 
observations show that neutralizing pneumolysin by either preventing its oligomerization in host membrane or 
preventing its initial binding to membrane cholesterol, attenuates its genotoxicity. Thus, these studies suggest that 
membrane binding and oligomerization are critical for pneumolysin-induced host cell DNA damage.
Having shown that neutralization of pneumolysin inhibits pneumolysin induced cytotoxicity and DNA dam-
age, we next asked about the importance of oligomerization in cell cycle arrest. We found that neutralizing pneu-
molysin oligomerization not only reduced DNA damage (Fig. 5C), but it also prevented pneumolysin-induced 
cell cycle arrest (Fig. 5D). This observation is consistent with a model wherein pneumolysin-induced DSBs lead to 
cell cycle arrest. Further, to extend from recombinant pneumolysin to a more physiologically relevant condition, 
we studied genotoxicity associated with pneumococcal lysate. Alveolar epithelial cells were exposed to pneu-
mococcal lysate, along with the mAb. Consistent with the results using recombinant pneumolysin, the presence 
of anti-pneumolysin neutralizing mAb significantly reduced the frequency of γ H2AX positive cells (Fig. 5E), 
demonstrating that pneumolysin plays a critical role in mediating DNA damage when pneumococci undergo lytic 
death. Together, these data show that pneumolysin released during bacterial lysis is an important genotoxic factor 
in pneumococcal lysate, and that pneumolysin oligomerization and binding underpin its genotoxicity.
Discussion
S. pneumoniae infection underlies 30–50% of pneumonia cases, amounting to 1–2 million deaths per year41. 
While antibiotics have been a mainstay for treating S. pneumoniae infection, antibiotic resistance is a growing 
problem, calling attention to the need for alternative approaches for disease mitigation. Here, to explore strategies 
for treating pneumococcal infection, we studied the underlying molecular processes by which S. pneumoniae 
induces cell death. Specifically, we studied the pneumococcal toxin pneumolysin, which is present in almost all 
of the pathogenic pneumococcal strains1. While pneumolysin’s ability to kill cells and damage tissue is well estab-
lished12–16, little is known about the underlying molecular processes that drive cytotoxicity. Recent studies point 
to DNA damage as a mechanism of pathogenicity during infection20,21. Here, we show that pneumolysin has a 
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Figure 3. Pneumolysin-induced DNA damage is associated with cell cycle arrest. (A) Alveolar epithelial cells 
exposed to pneumolysin were lysed at different time-points during incubation and the lysate was probed for 
p53 and p21 by western blot. β -actin served as loading control. Each blot is representative of three independent 
experiments. Protein band intensity analysis was done on all three experiments and is expressed as fold change 
relative to ‘media only’ control after normalizing with β -actin. (B) Cells exposed to pneumolysin were also 
analyzed for cell cycle using propidium iodide. Representative histograms of three independent experiments 
showing alveolar epithelial cell arrest at 4N DNA content after treatment with pneumolysin for 48 h. Percentage 
cell cycle arrest at 12, 24 and 48 h was quantified. Results show mean ± SEM for three independent experiments. 
*p < 0.05, unpaired Student’s t-test.
www.nature.com/scientificreports/
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previously unidentified impact on genomic integrity and that pneumolysin-induced DNA damage is associated 
with cell cycle arrest and cytotoxicity.
To learn about the potential for pneumolysin to induce DNA damage, we monitored the formation of γ H2AX 
repair foci that are known to form at sites of DSBs. We observed that pneumolysin is a potent inducer of DSBs. 
Further, pneumolysin-induced γ H2AX foci are mediated by ATM and DNA-PK kinases, and they recruit 53BP1 
and MDC1 to the sites of DSBs. At a clinically relevant concentration of pneumolysin (i.e. 100 ng/ml)6, the toxin 
was able to induce discrete repair foci at DSBs without any cell lysis, suggesting that pneumolysin’s genotoxicity 
can occur independently of its characteristic function as a cytolysin. Pneumolysin-induced DSBs caused cell cycle 
arrest, without significant apoptosis. In line with this observation, we found that inhibiting the NHEJ DNA repair 
pathway during pneumolysin exposure led to increased levels of toxicity and apoptosis. Further, we found that 
neutralizing the oligomerization domain of pneumolysin prevents pneumolysin-induced DNA damage and cell 
cycle arrest, indicating a potential role of pneumolysin oligomerization in activating host DNA damage response. 
Finally, we showed that pneumolysin is the key DNA damaging factor released during bacterial lysis. Overall, 
Figure 4. Association between pneumolysin-induced γH2AX and DNA replication. (A) Alveolar cells 
incubated with pneumolysin for 4, 12 and 48 h were labeled with EdU for 30 min at the end of each time point. 
The cells were then fixed and probed for γ H2AX and EdU. Representative images showing nuclei (blue), 
γ H2AX (red) and EdU (yellow). Images are representative from three independent experiments. (B) γ H2AX, 
EdU positive (≥ 5 foci per nucleus) and dual-positive cells were quantified and expressed as percentage positive 
cells. ‘Media only’ indicates negative control without pneumolysin. Results show mean ± SEM for three 
independent experiments.
www.nature.com/scientificreports/
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these results demonstrate the genotoxicity of pneumococcal pneumolysin and underscore the importance of 
DNA repair to counteract pneumolysin-mediated toxicity.
Pneumolysin is released from pneumococci when they are lysed4–6. Among the most common frontline anti-
biotics against S. pneumoniae are β -lactams42 which, while effective in killing the bacteria, lead to the release of 
pneumolysin, as has been demonstrated in both in vitro and in vivo models6,43. Hence, despite antibiotic-based 
treatment against bacterial pneumonia44, there are studies showing antibiotic therapy to be insufficient for treat-
ment of patients in the intensive care unit2. In addition, significant concentrations of pneumolysin have been 
detected in cerebral spinal fluid of patients with pneumococcal diseases, sometimes up to 180 ng/ml6, which is 
significantly higher than the dose of pneumolysin that we showed here as genotoxic. Given pneumolysin’s acute 
pathogenicity, it is important to understand the molecular processes underlying the toxicity of pneumolysin.
CDC toxins are traditionally known for their role in cell lysis45. In the context of pneumolysin’s effect on 
nuclear DNA, one study demonstrated that pneumolysin specifically induces dephosphorylation of histone H3 
at serine 10, through unidentified pathways, as a potential mechanism for host transcription regulation46. Here, 
we show that pneumolysin is able to induce H2AX phosphorylation at serine 139, a modification that is created 
along ~ 1–2 Mbp around a DSB47. There are potential mechanisms by which pneumolysin could be inducing 
DNA damage. While pneumolysin pore formation causes leakage of cytoplasmic protein and lysis via macropo-
res (~26 nm), pneumolysin can also form ion channel-like micropores that can facilitate calcium influx17,48 and 
Figure 5. Neutralizing oligomerization domain of pneumolysin prevents its genotoxicity. (A) Hemolysis assay 
was performed to test the ability of anti-pneumolysin monoclonal antibody (mAb) to neutralize the lytic activity 
of 25 ng/ml pneumolysin against RBCs. Extent of hemoglobulin released during pneumolysin-mediated RBC 
lysis is expressed as percentage of total hemolysis during RBC treatment by lysis buffer. (B) Alveolar epithelial cells 
were exposed to pneumolysin for 12 h in the presence of anti-pneumolysin mAb. LDH assay was performed on the 
culture supernatant, and expressed as percentage of total LDH released during lysis by 1% Triton X-100. Similarly, 
alveolar epithelial cells exposed to pneumolysin, in the presence of anti-pneumolysin mAb, were analyzed for (C) 
γ H2AX at 12 h and (D) cell cycle arrest at 24 h and 48 h. (E) Alveolar epithelial cells were exposed to pneumococcal 
lysate for 7 h in the presence of anti-pneumolysin mAb. Representative images from three independent 
experiments showing prevention of DNA damage by mAb, with nuclei (blue) and γ H2AX (red). Results show 
mean ± SEM for three independent experiments. *p < 0.05, unpaired Student’s t-test.
www.nature.com/scientificreports/
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activate different signaling pathways48,49. Increased cytosolic calcium levels can stimulate the electron transport 
chain and membrane enzyme NADPH-oxidase to cause dysregulated production of intracellular reactive oxygen 
species (ROS)50, which can inflict direct DNA damage51. Indeed, ≤ 100 ng/ml of pneumolysin has been shown 
to elevate ROS production in neuronal cells52 and neutrophils53. Increased calcium levels can also induce DNA 
damage via activation of endonucleases that require calcium for their activity to cleave DNA strands54. Although 
changes in calcium flux could be a plausible reason for pneumolysin-induced DNA damage, further studies are 
warranted to elucidate the detailed mechanisms.
While intracellular ROS could mediate pneumolysin-induced DSBs, single strand breaks (SSBs) produced 
by ROS damage could also be a source of DSBs. SSBs encountered by replication forks can lead to replication 
fork breakdown, and if the SSBs are in close proximity, a DSB can be formed39, leading to γ H2AX formation. 
We observed that at 12 hours there is a substantial population of γ H2AX and EdU-positive cells. Importantly, 
at 48 hours, the dual positive cells are insignificant in numbers while the γ H2AX positive cells persist. These 
results indicate that the observed increase in γ H2AX is mainly induced by pneumolysin and not an intrinsic 
cell cycle event. Although our study did not address the direct role of replication stress on pneumolysin-induced 
H2AX phosphorylation, the observation that a sub-population of γ H2AX-positive cells was also positive for EdU 
incorporation indicates that pneumolysin-induced DNA damage could arise during replication stress or fork 
breakdown.
PI3KKs play important roles in response to DNA damage27. We observed that increasing the concentration 
of inhibitors of ATM and DNA-PK (KU55933 and NU7441 respectively), increased the extent of ATP depletion 
and detachment of adherent epithelial cells during pneumolysin treatment. Importantly, disrupting the NHEJ 
repair process by inhibiting DNA-PK with NU7441, sensitized the pneumolysin-exposed epithelial cells to apop-
tosis. This observation that pneumolysin is able to induce apoptosis when DNA-PK mediated repair is inhibited, 
demonstrates that DSB repair pathway is essential against pneumolysin-induced genotoxicity. The toxic effect 
of NU7441 was also demonstrated by ATP reduction in epithelial cells that were not exposed to pneumolysin. 
ATM inhibition by KU5593355 resulted in decreased γ H2AX formation by pneumolysin, which is consistent with 
a role for ATM in phosphorylating H2AX in response to pneumolysin-induced DSBs formation. Interestingly, 
DNA-PK inhibition by NU7441 was also able to significantly reduce pneumolysin-induced γ H2AX foci for-
mation. This could be partly attributed to the redundant ability of DNA-PK to generate γ H2AX32. In addition, 
both NU7441 and KU55933 are designed as ATP-competitive inhibitors of DNA-PK and ATM, respectively. It is 
possible that using NU7441 throughout pneumolysin treatment, could have non-competitive and non-specific 
inhibition of related phosphatidylinositol-3’ kinases (including ATM and ATR) that phosphorylate H2AX. Taken 
together, these observations suggest that pneumolysin-induced DSBs activate ATM pathway and depend on 
DNA-PK-mediated NHEJ pathway for DNA repair in order to prevent apoptosis.
We observed that pneumolysin-induced DSBs in alveolar cells precede cell cycle arrest, which is possibly 
mediated by p21 pathway. During DNA damage, p53 regulates cell arrest and apoptosis33. During pneumolysin 
treatment, although p53 protein levels were not substantially elevated, p21 was significantly upregulated. Previous 
studies34,35 have shown that p53 is differentially activated in long and short pulses depending on the severity of 
DNA damage, to regulate either cell arrest and survival or cell death. p53 levels are greatly increased and sus-
tained to execute apoptosis, however, lower levels of p53, possibly activated in short pulses, may contribute to 
cell cycle arrest34,35. Hence, one possible reason for absence of significant p53 induction in our observation could 
be that p53 is activated in short pulses to facilitate cell arrest until repair is completed34,35. Indeed, low levels of 
p53 have been demonstrated to induce p21 expression and cause cell cycle arrest56,57. Overall, the results shown 
here are consistent with a role for p53-p21 pathway in cell cycle arrest, leaving time for repair in order to prevent 
apoptosis.
With the prevalent use of bacteriolytic antibiotics in treatment of pneumococcal diseases, host cells are certain 
to be exposed to pneumolysin. Concentration of pneumolysin (< 100 ng/ml) that does not lyse mammalian cells, 
is shown to induce production of inflammatory factors in immune cells18,19. Here, we show that pneumococcal 
lysis releases pneumolysin as a genotoxic factor, suggesting that the use of bacteriolytic antibiotics during pneu-
mococcal diseases may exacerbate host DNA damage. Pneumolysin-induced DNA damage could aggravate the 
collateral damage done by ROS-producing inflammatory cells, culminating in increased genomic damage that 
could trigger cell death. Importantly, regeneration and repair of alveolar cells are critical to restore functional pul-
monary architecture in the aftermath of pathogen-induced lung injury58. Pneumolysin-induced cell cycle arrest in 
alveolar cells could impair or delay tissue repair and regeneration processes during the recovery phase.
In summary, these studies reveal a previously unidentified ability of pneumococcal pneumolysin to induce 
DSBs, at pathologically relevant concentration. Interestingly, the genotoxicity of pneumolysin is dependent on its 
binding and oligomerization on the host cell membrane, and may not require membrane lysis. Importantly, we 
showed that pneumolysin-induced DSBs elicit DNA damage response that involves activation of NHEJ pathway 
to repair the DSBs and subsequent p21-mediated cell cycle arrest to allow time for DNA repair. Pneumolysin 
is closely related to other toxins of the CDC family such as listeriolysin, streptolysin and perfingolysin that are 
produced by various pathogenic bacteria59. Given that pneumolysin shares 40–70% sequence identity with these 
toxins59, this study encourages future investigation of these CDC toxins for potential genotoxicity during disease 
pathogenesis.
Materials and Methods
Cell culture. Human lung alveolar carcinoma (type II pneumocyte) A549 cell line was maintained in F12-K 
medium (Gibco) with 15% fetal bovine serum at 37 °C and 5% CO2. Cells were seeded at 2 × 105 cells/ml for all 
experiments.
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Preparing bacterial protoplast lysate. Protoplasts were isolated as described previously60. Briefly, 2 ml 
of bacterial culture (serotype 3 Xen 10 A66.1, serotype 4 TIGR4 and serotype 19 F clinical isolate), grown in brain 
heart infusion broth (with serum) for 8 h, were centrifuged, washed with PBS and re-suspended in 100 μl of cell 
wall digestion buffer (10 mM Tris pH 7.5, 30% Sucrose, 1x protease inhibitor, 300 U/ml mutanolysin, 1 mg/ml 
lysozyme) for 3 h at 37 °C. The protoplasts were pelleted at 6000 rpm for 10 min at 4 °C, washed and resuspended 
in F-12 K media. Protoplasts were lysed with 100 μl volume of 0.1 mm silica beads (Biospec) in Tissuelyser II 
(Qiagen) at 30 beats/sec for 10 min. The lysate was centrifuged and the supernatant was filter sterilized, made up 
to 1 ml with F-12 K medium and incubated with A549 cells. The supernatant was also plated out to confirm the 
absence of bacterial colonies.
Treatment of cells. Chemical inhibitors KU55933 and NU7441 (Selleckchem) were dissolved in DMSO 
and stored as 2 mM stock. Each inhibitor (10 or 20 μM), dissolved in F12-K media, was incubated with A549 cells 
for up to 6 h. To detect DNA replication, 10 μM EdU (Invitrogen) was incubated in F12-K medium for 30 min 
at 37 °C. ATP level in cell culture was determined in 96-well plate by using Cell Titre-Glo luminescent assay 
(Promega).
Recombinant pneumolysin. pET101 vector containing pneumolysin sequence with C-terminal His-tag 
was a generous gift from Prof. Larry S. McDaniel (University of Mississippi Medical Center). The plasmid was 
transformed into competent E. coli One shot BL21 (DE3) (Invitrogen) for recombinant protein expression by 
1 mM IPTG induction. The bacterial pellets were sonicated in buffer (100 mM Potassium Phosphate buffer pH 
8, 300 mM NaCl, Protease inhibitor) at 6 sec pulse on and off cycle (25–30% amplitude, Sonics Vibracell) for 
30 min, keeping the suspension in ice. The sonicated suspension was centrifuged at high speed and supernatant 
was subjected to binding with equilibrated Ni-NTA slurry (Qiagen) and 25 mM imidazole at 4 °C for 4 h. The 
slurry was then loaded into a column, and washed with buffer (20 ml for 40 ml lysate). The recombinant pneumo-
lysin bound to the column was then eluted using increasing concentrations of imidazole (75, 100, 150, 200 mM). 
Protein purity of each elution was checked using SDS-PAGE. The elutions containing pure protein (single band 
in SDS-PAGE) were pooled and dialyzed overnight at 4 °C in 10 kDa membrane against 50 mM Tris-Cl pH 8 and 
20% glycerol. Recombinant protein was concentrated using an Amicon ultra filter (3 kDa cutoff). The final protein 
concentration was determined by Biorad protein assay, diluted with buffer (50 mM Tris-Cl pH 8, 150 mM NaCl, 
20% glycerol), aliquoted and stored at − 20 °C.
Pneumolysin Neutralization assay. The neutralizing effect of anti-pneumolysin monoclonal antibody 
was tested against 25 ng/ml pneumolysin. Antibody was diluted to 100 μg/ml, and then serially diluted at 1:2 ratio. 
Each antibody dilution (100 μl) was added to recombinant pneumolysin for 5 min. RBCs was added to the mix-
ture, and incubated at 37 °C for 20 min. The cells were centrifuged and supernatant was measured at OD541 nm. 
The percentage hemolysis was calculated as the percentage of total lysis by RBC lysis buffer (Gibco).
Immunofluorescence. After incubation with pneumolysin, cells were permeabilized with 0.2% Triton 
X-100 in PBS for 10 min, and blocked with 3% bovine serum albumin (BSA) in PBS for 40 min. Primary anti-
bodies against γ H2AX (Ser-139) (Millipore #05–636), 53BP1 (Santa Cruz #sc-22760), MDC1 (Abcam #1169), 
p53BP1 (S1778, Cell signaling #2675) were used at 1:100 dilutions in PBS, and incubated for 1 h at room temper-
ature with cover slips. For TUNEL staining, the labeling enzyme (Roche #1 1684795 910) was incubated similarly 
for 1 h at 37 °C. Secondary antibodies (Invitrogen) labeled with either Alexa Fluor 488 or 564 or 647 were used. 
For EdU detection, Alexa Fluor azide was used in Click-iT reaction buffer (Invitrogen). Slides were mounted with 
SlowFade (Invitrogen) and stored at 4 °C until imaging. All stained slides were examined under confocal micro-
scope, and 15 images (at 5 × 3 sites) were taken for each well under 40X magnification.
DNA damage quantification. Cell imaging and enumeration were performed using Zeiss Zen microscope 
in the dark room. Cells within 15 images per condition were counted. Cells were observed as those with (a) > 5 
distinct foci of γ H2AX or 53BP1 (b) nuclei with colocalized foci of γ H2AX and 53BP1, or colocalized γ H2AX 
and EdU. Cells that showed colocalization of FITC and DAPI were counted as TUNEL positive cells. Nuclei were 
selected by DAPI channel alone, and subsequently analyzed under fluorescent channels.
Cell arrest analysis. Trypsinized cells were washed and resuspended in 1% paraformaldehyde and placed 
on ice for 1 h. After washing with PBS, cells were resuspended in 200 μl PBS and added with 1 ml of 70% ethanol 
(dropwise) and kept overnight at 4 °C. Cells were washed and resuspended in PBS containing 60 μg/ml propidium 
iodide and 100 μg/ml RNAse for 30 min at 37 °C. After wash, the cells were analyzed by flow cytometer.
Western analysis. Treated cells were washed with PBS, and incubated for 10 min with 200 μl of 1 x lysis buffer 
(50 mM Tris-HCl pH 6.8, 25 mM dithiothrietol, 2% SDS, 10% glycerol). The lysate was centrifuged for 10 min at 4 °C 
and the supernatant was denatured at 100 °C for 10 min and stored at − 20 °C. Protein concentration was quantified 
using the BioRad DC protein assay kit, and lysates were electrophoresed in 10% SDS-PAGE. Analysis was done using 
anti-p53, anti-p21 and β -actin (Santa Cruz) antibodies and with secondary antibody conjugated with HRP (Dako), 
and later developed by adding Amersham ECL prime reagent (GE Life Science). Blots were exposed on Kodak film 
and band intensities were quantified using Thermo Scientific myImageAnalysis v1.1.
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